erlotinib Articles
Update: AstraZeneca to do safety trial of Iressa
17 February 2003
AstraZeneca to do safety trial of Iressa
17 February 2003
Tarceva trial in NSCLC enrolled
12 August 2002
Roche stock performance begins to improve
22 July 2002
OSI acquires oncology assets from Gilead in $200 million deal
27 November 2001
OSI starts additional trials of anti-EGFr drug
25 October 2001
Promising data for anti-EGFR therapy Tarceva
15 May 2001
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
